La cadena de opciones muestra datos clave de las opciones de acciones de Real Good Food Co a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Real Good Food Co..

Real Good Food Co (OTC:RGFC) Bolsa, Cadena de Opciones

The Real Good Food Co Inc is a frozen food company that develops, markets, and manufactures foods high in protein, low in sugar, and gluten- and grain-free. The company produces breakfast sandwiches, entrees, and other products, primarily sold in the U.S. frozen food category. All of its revenue is derived from the United States.

THE REAL GOOD FOOD A NEW by The Real Good Food Company, Inc.

The Real Good Food Co Inc

Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) has outperformed the market over the past 15 years by 1.69% on an annualized basis producing an average annual return of 13.89%. Currently, Starbucks has a market capitalization of $101.62 billion. 
Buying $1000 In SBUX: If an investor had bought $1000 of SBUX stock 15 years ago, it would be worth $7,081.81 today based on a price of $89.40 for SBUX at the time of writing.
<h3>Starbucks's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754001915_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

SBUX

Here's How Much $1000 Invested In Starbucks 15 Years Ago Would Be Worth Today

Barclays analyst Manav Patnaik maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Overweight and raises the price target from $610 to $620.

Price Target

Analyst Ratings

SPGI

Barclays Maintains Overweight on S&P Global, Raises Price Target to $620

Barclays analyst Saket Kalia maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and raises the price target from $695 to $715.

Barclays Maintains Overweight on Tyler Technologies, Raises Price Target to $715

Barclays analyst Andrew Mok upgrades Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) from Underweight to Equal-Weight and raises the price target from $9 to $13.

Upgrades

ALHC

Barclays Upgrades Alignment Healthcare to Equal-Weight, Raises Price Target to $13

Barclays analyst Seth Sigman upgrades Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) from Equal-Weight to Overweight and raises the price target from $173 to $185.

Barclays Upgrades Sprouts Farmers Market to Overweight, Raises Price Target to $185

Barclays analyst Jeffrey Bernstein maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Overweight and raises the price target from $410 to $440.

WING

Barclays Maintains Overweight on Wingstop, Raises Price Target to $440

Barclays analyst Ramsey El-Assal maintains Western Union (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) with a Underweight and lowers the price target from $10 to $8.

Barclays Maintains Underweight on Western Union, Lowers Price Target to $8

PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) has outperformed the market over the past 10 years by 7.75% on an annualized basis producing an average annual return of 19.39%. Currently, PTC has a market capitalization of $25.85 billion. 
Buying $1000 In PTC: If an investor had bought $1000 of PTC stock 10 years ago, it would be worth $5,885.21 today based on a price of $214.81 for PTC at the time of writing.
<h3>PTC's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754001014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Barclays analyst Raimo Lenschow maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Overweight and raises the price target from $396 to $408.

Barclays Maintains Overweight on Visa, Raises Price Target to $408

Barclays analyst Julian Mitchell maintains Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) with a Equal-Weight and raises the price target from $110 to $128.

Barclays Maintains Equal-Weight on Vertiv Holdings, Raises Price Target to $128

Barclays analyst Brandon Oglenski maintains United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) with a Underweight and lowers the price target from $90 to $80.

Barclays Maintains Underweight on United Parcel Service, Lowers Price Target to $80

Barclays analyst Jared Shaw maintains UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Overweight and raises the price target from $140 to $150.

UMBF

Barclays Maintains Overweight on UMB Financial, Raises Price Target to $150

WIIM

ROKU

ROKU stock has given up its prior gain. Roku shares were trading higher after the company reported better-than-expected Q2 financial results and issued Q3 sales guidance above estimates.

Enovix Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) reported financial results for the second quarter after the market close on Thursday. Shares are moving <a href="http://benzinga.com/quote/ENVX/earnings">lower in after-hours trading</a>. Here&#8217;s a look at the key highlights<a href="https://www.benzinga.com/pressreleases/25/07/g46774376/enovix-announces-second-quarter-2025-financial-results"> from the quarter</a>.
<ul class="wp-block-list">
<li>Q2 Revenue: $7.47 million, versus <a href="http://benzinga.com/quote/ENVX/earnings">estimates</a> of $5.57 million</li>
</ul>
<ul class="wp-block-list">
<li>Q2 Adjusted EPS: Loss of 13 cents, versus estimates for a loss of 17 cents</li>
</ul>
Total revenue was up 98% on a year-over-year basis, driven by &#8220;strong demand&#8221; for the lithium-ion battery&nbsp;company&#8217;s products. Enovix highlighted the launch of its AI-1 cell platform, a core battery architecture featuring advanced materials and a fully automated manufacturing process.
&#8220;In the second quarter of 2025, Enovix delivered on key milestones in product development, manufacturing readiness and commercialization. We finalized the AI-1 battery platform, shipped production samples for product qualification, exceeded revenue expectations, and achieved our third straight quarter of positive gross margin,&#8221; the company said in a letter to shareholders.
&#8220;With AI-1 launched, mass production advancing, and new customers entering qualification, we are moving into the commercialization phase.&#8221;
Enovix ended the period with $203.4 million in total cash, cash equivalents and short-term investments.
Guidance: Enovix expects third-quarter revenue to be between $7.5 million and $8.5 million versus estimates of $7.3 million. The company anticipates a third-quarter loss of 14 cents to 18 cents per share versus estimates for a loss of 18 cents per share. 
ENVX Price Action: <a href="http://benzinga.com/quote/ENVX">Enovix shares</a> were down 17.61% in after-hours, trading at $11.04 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46774978/amazon-q2-earnings-highlights-double-beat-ai-progress-across-the-board-continues">Amazon Q2 Earnings Highlights: Double Beat, &#8216;AI Progress Across The Board Continues&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/07/46711313/elon-musks-tesla-lg-energy-solutions-sign-4-3-billion-battery-deal-report">Elon Musk&#8217;s Tesla, LG Energy Solutions Sign $4.3 Billion Battery Deal</a></li>
</ul>
Image: Tada Images/Shutterstock.com

Earnings

After-Hours Center

Movers

ENVX

Enovix Stock Is Tumbling Thursday: What's Going On?

Barclays analyst Julian Mitchell maintains Trane Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) with a Overweight and raises the price target from $480 to $495.

Barclays Maintains Overweight on Trane Technologies, Raises Price Target to $495

Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) has outperformed the market over the past 15 years by 12.47% on an annualized basis producing an average annual return of 24.67%. Currently, Mastercard has a market capitalization of $513.70 billion. 
Buying $100 In MA: If an investor had bought $100 of MA stock 15 years ago, it would be worth $2,809.45 today based on a price of $565.65 for MA at the time of writing.
<h3>Mastercard's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1754000114_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Mastercard 15 Years Ago Would Be Worth Today

Barclays analyst Benjamin Budish maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Overweight and raises the price target from $102 to $120.

HOOD

Barclays Maintains Overweight on Robinhood Markets, Raises Price Target to $120

Barclays analyst Saket Kalia maintains PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) with a Overweight and raises the price target from $203 to $233.

Barclays Maintains Overweight on PTC, Raises Price Target to $233

Barclays analyst Lauren Lieberman maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Equal-Weight and raises the price target from $161 to $164.

Barclays Maintains Equal-Weight on Procter & Gamble, Raises Price Target to $164

Barclays analyst Tavy Rosner maintains Radware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDWR#NASDAQ">RDWR</a>) with a Overweight and raises the price target from $30 to $35.

Comments

Real Good Food Co

Real Good Food Co (RGFC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL